313 related articles for article (PubMed ID: 32775974)
21. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
[TBL] [Abstract][Full Text] [Related]
23. Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
Türker F; Oral A; Şahin T; Türker BÇ; Koçak E; Ataoğlu HE; Ahbab S
J Int Med Res; 2021 Nov; 49(11):3000605211056841. PubMed ID: 34763561
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath.
Verdam FJ; Dallinga JW; Driessen A; de Jonge C; Moonen EJ; van Berkel JB; Luijk J; Bouvy ND; Buurman WA; Rensen SS; Greve JW; van Schooten FJ
J Hepatol; 2013 Mar; 58(3):543-8. PubMed ID: 23142062
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
26. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
Huang C; Seah JJ; Tan CK; Kam JW; Tan J; Teo EK; Kwek A; Wong YJ; Tan M; Ang TL; Kumar R
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101528. PubMed ID: 33268036
[TBL] [Abstract][Full Text] [Related]
27. Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience.
Rath MM; Panigrahi MK; Pattnaik K; Bhuyan P; Kar SK; Misra B; Misra D; Meher C; Agrawal O; Rath J; Singh SP
J Clin Exp Hepatol; 2016 Dec; 6(4):291-296. PubMed ID: 28003718
[TBL] [Abstract][Full Text] [Related]
28. Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls.
Eng K; Alkhouri N; Cikach F; Patel N; Yan C; Grove D; Lopez R; Rome E; Dweik RA
J Breath Res; 2015 Apr; 9(2):026002. PubMed ID: 25891513
[TBL] [Abstract][Full Text] [Related]
29. Use of simple scoring systems for a public health approach in the management of non-alcoholic fatty liver disease patients.
Zain SM; Tan HL; Mohamed Z; Chan WK; Mahadeva S; Basu RC; Mohamed R
JGH Open; 2020 Dec; 4(6):1155-1161. PubMed ID: 33319051
[TBL] [Abstract][Full Text] [Related]
30. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease.
Koo BK; Joo SK; Kim D; Lee S; Bae JM; Park JH; Kim JH; Chang MS; Kim W
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2592-2599.e10. PubMed ID: 32062042
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease.
Shima T; Sakai K; Oya H; Katayama T; Mitsumoto Y; Mizuno M; Kanbara Y; Okanoue T
J Gastroenterol; 2020 Jan; 55(1):100-112. PubMed ID: 31538241
[TBL] [Abstract][Full Text] [Related]
33. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
34. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease.
Fierbinteanu Braticevici C; Sporea I; Panaitescu E; Tribus L
Ultrasound Med Biol; 2013 Nov; 39(11):1942-50. PubMed ID: 23932277
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography.
Zhang D; Li P; Chen M; Liu L; Liu Y; Zhao Y; Wang R
Abdom Imaging; 2015 Apr; 40(4):723-9. PubMed ID: 24811766
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of imaging methods for steatohepatitis diagnosis in non-alcoholic fatty liver disease patients: A systematic review.
Besutti G; Valenti L; Ligabue G; Bassi MC; Pattacini P; Guaraldi G; Giorgi Rossi P
Liver Int; 2019 Aug; 39(8):1521-1534. PubMed ID: 30972903
[TBL] [Abstract][Full Text] [Related]
38. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
[TBL] [Abstract][Full Text] [Related]
40. Embedding assessment of liver fibrosis into routine diabetic review in primary care.
Mansour D; Grapes A; Herscovitz M; Cassidy P; Vernazza J; Broad A; Anstee QM; McPherson S
JHEP Rep; 2021 Aug; 3(4):100293. PubMed ID: 34179738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
